Tilak Mandadi has sold CVS and made no open-market buys since May 2026
EVP, Chief Exp & Tech Officer at CVS Health Corporation
SEC CIK 0001872827 · Filings on SEC.gov ↗
$0Bought
$6.2MSold
NoneLast buy
Every filing
1 filing since May 2026, newest first
Filings come from SEC EDGAR. Not investment advice.